Advertisement

Topics

Hyaluronic acid Sanofi - Biotech, Pharma and Life Science Channel

03:57 EST 27th February 2017 | BioPortfolio

PubMed Articles [7647 Associated PubMed Articles listed on BioPortfolio]

Ultrasonic modification of carbon materials for electrochemical capacitors.

The paper is devoted to study the ultrasonic impact on the biomass of natural raw materials, which were used for the creation a nanoporous carbon material (NCM), which was used as electrode material f...

Tuning the Synthesis of Manganese Oxides Nanoparticles for Efficient Oxidation of Benzyl Alcohol.

The liquid phase oxidation of benzyl alcohol is an important reaction for generating benzaldehyde and benzoic acid that are largely required in the perfumery and pharmaceutical industries. The current...

Pretreatment optimization of the biomass of Microcystis aeruginosa for efficient bioethanol production.

Microalgae are considered to be the future promising sources of biofuels and bio products. The algal carbohydrates can be fermented to bioethanol after pretreatment process. Efficient pretreatment of ...

Heat Transfer Capability of (Ethylene Glycol + Water)-Based Nanofluids Containing Graphene Nanoplatelets: Design and Thermophysical Profile.

This research aims at studying the stability and thermophysical properties of nanofluids designed as dispersions of sulfonic acid-functionalized graphene nanoplatelets in an (ethylene glycol + water) ...

Antihyperlipidaemic effect of triterpenic acid-enriched fraction from Cyclocarya paliurus leaves in hyperlipidaemic rats.

Cyclocarya paliurus (Batal) Iljinskaja (Juglandaceae) is an edible and medicinal plant; the leaves are used in Chinese folkloric medicine to treat dyslipidaemia and diabetes.

Epigenetic modifier induced enhancement of fumiquinazoline C production in Aspergillus fumigatus (GA-L7): an endophytic fungus from Grewia asiatica L.

Present study relates to the effect of valproic acid, an epigenetic modifier on the metabolic profile of Aspergillus fumigatus (GA-L7), an endophytic fungus isolated from Grewia asiatica L. Seven seco...

PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies.

This article reports a promising approach to enhance the oral delivery of nuciferine (NUC), improve its aqueous solubility and bioavailability, and allow its controlled release as well as inhibiting l...

Mutantelec: An In Silico mutation simulation platform for comparative electrostatic potential profiling of proteins.

The electrostatic potential plays a key role in many biological processes like determining the affinity of a ligand to a given protein target, and they are responsible for the catalytic activity of ma...

Diet and gastroesophageal reflux disease: role in pathogenesis and management.

Gastroesophageal reflux disease (GERD) is a common disease that presents with a variety of symptoms including heartburn and acid regurgitation. Although dietary modification is currently regarded as f...

Intra and inter species genetic variability of transferrin receptor gene regions in Trypanosoma evansi isolates of different livestock and geographical regions of India.

Trypanosoma evansi, the aetiological agent of Surra affects a wide range of livestock and wild animals in India. In the present study, we studied intra- and inter species genetic variability in the tr...

News Articles [2362 Associated News Articles listed on BioPortfolio]

Sanofi, Lonza In Partnership To Build Swiss Biologics Production Facility

PARIS (dpa-AFX) - French drug giant Sanofi SA (SNYNF, SNY) and Lonza Group AG (LZAGF.PK), a supplier to the pharmaceutical, healthcare and life-science industries, announced Monday that they have ...

Lonza und Sanofi investieren knapp 300 Mio CHF in neues Werk in Visp

Beide Unternehmen haben eine strategische Partnerschaft zur Errichtung und zum Betrieb einer Anlage für Säugetierzellkulturen zur Herstellung von monoklonalen Antikörpern in Visp geschlossen. Die s...

Lonza Group AG: Sanofi und Lonza schliessen strategische Partnerschaft zur Errichtung einer Grossanlage für die Biologika-Produktion

Sanofi und Lonza schliessen strategische Partnerschaft zur Errichtung einer Grossanlage für die Biologika-Produktion In die Grossanlage, die im Rahmen eines Joint Venture in Visp, Schweiz, gebaut ...

Sanofi: Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility

Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility - The large-scale facility, to be built in Visp, Switzerland, will be established throu...

Sanofi and Lonza to build new $285 million Swiss biologics facility

PARIS (Reuters) - French drugmaker Sanofi and Swiss manufacturer Lonza will invest 270 million euros ($285 million) in a new large-scale biologics facility that will produce monoclonal antibodies by 2...

Sanofi and Lonza to build biologics facility in Switzerland

PARIS (Reuters) - French drugmaker Sanofi and Switzerland's Lonza will invest 270 million euros ($285 million) to build a large-scale biologics facility that will produce monoclonal antibodies by 2020...

MedyTox Inc 086900 Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryMedytox Inc Medytox is a biotechnology company that manufactures botulinum toxin biopharmaceuticals. The company's botulinium toxin products include Neuronox 50U, Neuronox and Neuronox 200U. It...

Aeglea BioTherapeutics Inc AGLE Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryAeglea BioTherapeutics Inc Aeglea BioTherapeutics, formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops engineered human enzymes and companion diagnostics for ...

Schnell Biopharmaceuticals Inc 003060 Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummarySchnell Biopharmaceuticals Inc Schnell, formerly Korea Schnell Pharma Co., Ltd. is a healthcare company that offers agents and antibiotics. The company provides pharmaceutical products includin...

#jobs #lifescience Medical Science Liaison, Multiple Sclerosis, North-East Territory

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Medical Science Liaison, Multiple Sclerosis, North-East Territory .MA-US Remo...

Events [0 Results]

None

Companies [80 Associated Companies listed on BioPortfolio]

DiaCarta, Inc.

DiaCarta is an innovative precision molecular diagnostic company headquartered in Richmond, California. The company has an ISO 13485-certified facility, which is used to develop, ...

Mission Bio, Inc.

Mission Bio, Inc. is innovating technologies to analyze single cells within complex biological systems, revealing critical information not observable from bulk sample analysis. Wi...

Sanofi Genzyme

WAVE Life Sciences Ltd.

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeut...

Pronutria Biosciences

Pronutria Biosciences is pioneering new nutritional and therapeutic modalities: amino acid biologics. Amino acids (AA) are known as the “building blocks of life,” and ar...

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed ...

MabSpace Biosciences Co., Ltd.

MabSpace Biosciences Co., Ltd. is a biotechnology company focused on the discovery and early development of antibody based therapeutics. The key advantage of its proprietary immun...

Pronutria Biosciences Inc.

Pronutria Biosciences is pioneering new nutritional and therapeutic modalities: amino acid biologics. Amino acids (AA) are known as the “building blocks of life,” and ar...

Merial

Merial is a world-leading, innovation-driven animal health company that provides a comprehensive range of products to enhance the health, well-being and performance of a wide rang...

Mirus Bio Corporation

Mirus Bio Corporation is a biopharmaceutical company focused on discovering, developing and commercializing innovative nucleic acid based technologies and products. The company currently markets a ran...

Clinical Trials [2019 Associated Clinical Trials listed on BioPortfolio]

The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study)

This sub-study aims to assess the effect and breakdown of lysine administration, specifically examining whether it leads to increased plasma 2-AAA in healthy humans.

Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms

Purpose of this study is to assess the hypothesis that a strategy with acetylsalicylic acid (ASA) 100 mg/day, intensive blood pressure treatment (targeted systolic blood pressure below 120...

Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion

Tranexamic Acid (TXA) is an antifibrolytic medication used in total hip and knee arthroplasty to reduce the need for intraoperative and postoperative blood transfusions. Limited research i...

Efficacy and Safety of Resveratrol and Lipoic Acid Transdermal Patch for Lipolysis in Overweight Volunteers

To evaluate the lipolysis effect of resveratrol and lipoic acid transdermal patch in overweight volunteers

Metformin in Intrahepatic Cholestasis of Pregnancy

This is a pilot study aimed at comparing the effect of metformin versus ursodeoxycholic acid in women with intrahepatic cholestasis in pregnancy. The study will be conducted in three NHS h...

Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets

The primary objective of this study is to compare the bioavailability of a single dose of a new 1000 mg fast release ASA (acetylsalicylic acid) tablet with that of two tablets of a commerc...

Health Professional Dietary Habits and Blood Omega-3 Fatty Acid Concentrations

Health professionals attending the American Association for Family Physicians (AAFP) meeting at the Orlando Convention Center, Sept 21-23, 2016 who visit the DSM booth will be invited to c...

Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables

During major surgical procedures, intravascular volume is maintained with the administration of isotonic fluids such as Lactated Ringers (LR), Normal Saline (NS) or Normosol-R. All three o...

Canola Oil Multi-center Intervention Trial II

Building on the findings from the investigators previous study, COMIT I, the purpose of the COMIT II study is to supplement the DEXA measurement of body composition with a supplementary DE...

Effect of Apple Polyphenols on Vascular Oxidative Stress and Endothelium Function Study (APP trial_2016)

Apple polyphenols are mostly acknowledged for their hypoglycaemic properties, but represent an apple active fraction with many pharmacological functions. The study aim was to examine their...

Videos

None available.

Medical and Biotech [MESH] Definitions

A group of high molecular weight chondroitin sulfate proteoglycans that form aggregates with HYALURONIC ACID.

Mucoid states characterized by the elevated deposition and accumulation of mucin (mucopolysaccharides) in dermal tissue. The fibroblasts are responsible for the production of acid mucopolysaccharides (GLYCOSAMINOGLYCANS) in the ground substance of the connective tissue system. When fibroblasts produce abnormally large quantities of mucopolysaccharides as hyaluronic acid, chondroitin sulfate, or heparin, they accumulate in large amounts in the dermis.

A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA.

A therapeutic treatment typically involving INTRA-ARTICULAR INJECTIONS of HYALURONIC ACID and related compounds. The procedure is commonly used in the treatment of OSTEOARTHRITIS with the therapeutic goal to restore the viscoelasticity of SYNOVIAL FLUID, decrease pain, improve mobility and restore the natural protective functions of hyaluronan in the joint.

An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature greying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.

Quick Search
Advertisement
 
review and buy Hyaluronic acid Sanofi market research data and corporate reports here

Channels Quicklinks